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Introduction: Amyotrophic lateral sclerosis is a progressive neurodegenerative disorder characterized by
degeneration of motoneuron cells in anterior spinal horns. There is a need for early and accurate diagnosis with
this condition. In this case report we used two complementary methods: scanning electron microscopy and
fluorescence-activated cell sorting. This is the first report to our knowledge of microparticles in the cerebrospinal
fluid of a patient with amyotrophic lateral sclerosis.
Case presentation: An 80-year-old Swedish man of Caucasian ethnicity presented to our facility with symptoms of
amyotrophic lateral sclerosis starting a year before his first hospital examination, such as muscle weakness and
twitching in his right hand progressing to arms, body and leg muscles. Electromyography showed classical
neurophysiological findings of amyotrophic lateral sclerosis. Routine blood sample results were normal. A lumbar
puncture was performed as a routine investigation and his cerebrospinal fluid was normal with regard to cell count
and protein levels, and there were no signs of inflammation. However, scanning electron microscopy and
fluorescence-activated cell sorting showed pronounced abnormalities compared to healthy controls. Flow
cytometry analysis of two fractions of cerebrospinal fluid from our patient with amyotrophic lateral sclerosis was
used to measure the specific binding of antibodies to CD42a, CD144 and CD45, and of phosphatidylserine to
lactadherin. Our patient displayed over 100 times more phosphatidylserine-positive microparticles and over 400
times more cell-derived microparticles of leukocyte origin in his cerebrospinal fluid compared to healthy control
subjects. The first cerebrospinal fluid fraction contained about 50% more microparticles than the second fraction.
The scanning electron microscopy filters used with cerebrospinal fluid from our patient were filled with compact
aggregates of spherical particles of lipid appearance, sticking together in a viscous batter. The quantitative increase
in scanning electron microscopy findings corresponded to the flow cytometry result of an increase in leukocyte-
derived microparticles.
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Conclusions: Microparticles represent subcellular arrangements that can influence the pathogenesis of
amyotrophic lateral sclerosis and may serve as biomarkers for underlying cellular disturbances. The increased
number of leukocyte-derived microparticles with normal cell counts in cerebrospinal fluid may contribute to the
amyotrophic lateral sclerosis inflammatory process by formation of immune complexes of prion-like propagation,
possibly due to misfolded proteins. The two complementary methods used in this report may be additional tools
for revealing the etiology of amyotrophic lateral sclerosis, for early diagnostic purposes and for evaluation of clinical
trials, long-term follow-up studies and elucidating the pathophysiology in amyotrophic lateral sclerosis.
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Amyotrophic lateral sclerosis (ALS) has previously been
described as a neurodegenerative disorder of upper and
lower motor neurons, involving the cerebral cortex, brain-
stem and spinal cord, with progressive muscle weakness.
However, recently, new evidence shows a more wide-
spread degeneration, including cognitive and/or behav-
ioral impairment. There is a clear association between
ALS and frontotemporal lobe dementia (FTD). In both
diseases a common protein can be found in TAR deoxy-
ribonucleic acid (DNA)-binding protein 43 (TDP-43) in
intra-neuronal inclusions [1]. Despite more than a hun-
dred years of research no etiology has been found to this
devastating disease; many theories have been put forward,
but the pathogenesis is still unknown.
In 2012 the European Federation of Neurological
Societies (EFNS) task force summarized the evidence
for the diagnosis and management of ALS and made
the following recommendations: ‘Patients with symptoms
suggestive of ALS should be assessed as soon as possible
by an experienced neurologist. Early diagnosis should
be pursued’.
An accurate diagnosis is critical. ALS largely remains a
clinical diagnosis based on signs of upper and lower
motor neuron degeneration. Supporting electrophysio-
logical studies such as electromyography (EMG) and ex-
clusion of other etiologies using neuroimaging such as
magnetic resonance imaging (MRI), are used routinely,
as are clinical laboratory tests [2]. However, there is ini-
tially a risk of a misdiagnosis [3]. This makes the search
for and finding of a biomarker for ALS all the more ur-
gent. Some have been proposed, but there is still a lack
of ALS-specific ones [4].
Patients with schizophrenia [5] and bipolar disorders
[6] have previously been shown to display spherical
micro-sized particles in their cerebrospinal fluid (CSF)
although the disease symptoms in psychosis are sup-
posed to mainly affect brain function. In the present
study we opted to use two complementary techniques,
fluorescence-activated cell sorting (FACS) [7] and scan-
ning electron microscopy (SEM) [5] in a patient withneurological issues with a robust somatic disease known
to engage the central nervous system (CNS) motor sys-
tem, where death of neurons occurs in the anterior
spinal cord more adjacent to the lumbar cerebrospinal
fluid than in diseases with cognitive symptoms.
Case presentation
An 80-year-old Swedish-born Caucasian man was re-
ferred to us from a private neurologist with a diagnosis of
possible ALS six months ago. His mother died from ALS
in her 80s, but no other relatives are known to have had
this disease. Until recently our patient had been physically
active, including participation in marathon running and
cross-country skiing. Two years ago he had experienced
a cardiac arrest but was successfully resuscitated. Aside
from that, he had been in good health. About one year
ago he started to experience a progressive weakness of his
right hand and arm. During the same period, cognitive
deterioration and personality changes appeared.
A neurophysiologic investigation including nerve con-
duction studies (NCS) and EMG were performed prior
to his first hospital visit, including all four extremities,
proximally and distally. The NCS showed normal sensory
and motor conduction velocities. The EMG showed spon-
taneous denervation activity, fasciculations and neuro-
genic motor unit aberrations including polyphasia and
reduced interference within all examined muscles (arms
and legs, both proximal and distal). The conclusion of the
neurophysiologist was that of a general motor neuron
disease. The neurological examination showed a pro-
found weakness of the right hand, a slight weakness
of the left hand, and muscle atrophies in the hands,
arms and shoulders. Fasciculations were widely spread
over arms, shoulders, thorax and legs. The deep ten-
don reflexes were normal and both plantar reflexes
reacted normal. The pain and touch sensations were
normal. An MRI scan of the spinal canal showed no
pathologic lesions of the spinal cord.
A routine analysis of the CSF was normal with regard
to cell count and protein concentration, and there were
no signs of ongoing inflammation. The serum and CSF
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tine blood sample results were normal (complete blood
count, clinical biochemistry tests including liver, kidney
and muscle, thyroid function tests, and electrolytes).
After receiving the results of these investigations, our
patient and his wife were informed about the diagnosis
of ALS, which was based on the following evidence: (1)
clinical signs of lower motor neuron involvement in
three regions (arms, thorax, and legs); (2) signs of upper
motor neuron involvement (preservation of deep tendon
reflexes (arms and legs); (3) electromyographic signs of
denervation, fasciculations and polyphasia within all
examined muscles, (4) absence of neuroimaging path-
ology; and (5) absence of evidence of other diseases.
According to the El Escorial Criteria [2] a ‘clinically
probable ALS’ was suggested (evidence of upper motor
neuron involvement was demonstrated in two regions).
An experienced neurologist performed the lumbar
puncture with our patient in a sitting position. The skin in
the lumbar region was washed with sterile cotton swabs
before the puncture. A fine disposable needle of Quincke
type, Becton, Dickinson and Company; 0.7 × 75mm (BD
AB, Stockholm, Sweden) was used. The needle was
inserted in the vertebral L3 to L4 inter-space and one trial
was sufficient for CSF to flow. The very first two drops
(100μL) of CSF were allowed to drip directly onto a poly-
carbonate filter, which was immediately vacuum dried by
a special bedside pump and gold plated for microscopic
examination. The following 200μL were collected straight
in a sterile test tube for immediate FACS analysis of cell-
derived microparticles (MP) in the fresh CSF. In summary,
we tested the first 100μL of CSF with SEM followed by
200μL CSF for FACS, then 100μL of a second fraction of
CSF for SEM, again followed by 200μL of CSF for FACS.
The collection of CSF from healthy subjects was part
of an ongoing study approved by the Regional Ethics
Committee in Stockholm (no. 2009/1221-32) and con-
ducted in accordance with the latest Helsinki Protocol.
Our patient and all control subjects consented orally
and in writing to participate in the study.
Electron Microscopy
For controls 200μL of the first 0.6mL fresh CSF aliquot
and 200μL of the following 12mL of fresh CSF were
allowed to drip directly on the surface of a polycarbon-
ate filter (Nuclepore, Inc., Pleasanton, CA, USA) with
0.6μm pores. The polycarbonate filters were specially
prepared by GP Plastic AB (Gislaved, Sweden) and sup-
plied by Sempore AB (Stockholm, Sweden). The filter
was fitted to an airtight device designed with flow chan-
nels, which allowed CSF particles to stream to the center
of the filter when vacuum suction was applied from
below. The pores of the filters were 0.6μm, ensuring that
all particles with larger diameter stayed on the filter (seeFigure 1). All remaining structures in the CSF were thus
concentrated in the center of the filter during drying by
vacuum suction. When the filters were completely dried
after about two minutes of vacuum suction, they were
subsequently coated in a JEOL JFC-1200 Fine Coater
(JEOL Tokyo, Japan) for two minutes with ionized gold
to a thickness of 40Å. The first and the second fractions
of CSF were handled in a similar way in preparation for
SEM, and all 17 healthy control subject samples were
treated in a similar way to the sample from our patient.
The SEM method used in the study has earlier detected
human immunodeficiency virus in CSF [8]. The total area
of each filter with a diameter of 1cm was examined using a
SEM microscope (Philips High Resolution SEM 515, Philips
Electronic Instruments, Eindhoven, The Netherlands). The
peripheral area outside the center was mostly free of
structures. Two SEM images of the central areas of the
filters were enlarged (×500 and × 2000).
Measurement of microparticles
The CSF samples were analyzed fresh within an hour
of collection. A total of 20μL of the sample was incu-
bated for 20 minutes in the dark with phalloidin-
Alexa-660 (Invitrogen, Paisley, UK), lactadherin-FITC
(Haematologic Technologies Inc., Vermont, USA), CD42a-
PE (BD, New Jersey, USA), CD144-APC (AH diagnostics
Ltd., Stockholm, Sweden) and CD45-PC7 (Beckman
Coulter, Inc. Brea, California, USA). MPs were measured
on a Beckman Coulter Gallios™ flow cytometer (Beckman
Coulter, Inc. Brea, California, USA). The MP-gate was
determined using megamix beads (BioCytex, Marseille,
France), which is a mix of three beads with diameters of
0.5μm, 0.9μm and 3μm, respectively. MPs were defined
as particles less than 1.0μm in size, negative to phalloidin
(in order to exclude cell membrane fragments [7]) and
positive to lactadherin (which binds to phosphatidylser-
ine). Later the MPs were sorted into particles positive for
CD42a (platelet origin), CD144 (endothelial origin) or
CD45 (leukocyte origin). Conjugate isotype-matched im-
munoglobulin (IgG1-FITC, IgG1-PE, IgG1-APC and
IgG1-PC7) with no reactivity against human antigens
was used as a negative control to define the background
noise in the cytometry analysis. The results are presented
as number of events in 45 seconds in the MP-gate during
45 seconds of measurement.
Findings of FACS and SEM
The results of the two complementary methods,
FACS and SEM, were available within two hours of
the lumbar punctures (Figure 2). Our patient’s sam-
ples displayed more than 100 times the number of
microparticles in CSF, measured as events of phos-
phatidylserine (PS)-positive MPs compared to the
CSF samples from four healthy controls (Table 1,
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CSF II x 2 000CSF I x 2 000
CSF II x 2 000CSF I x 2 000
Figure 1 Scanning electron microscopy (SEM) of two fractions of cerebrospinal fluid (CSF) from our patient with amyotrophic lateral
sclerosis (ALS) and a control subject. Cerebrospinal fluid was dripped onto the surface of a polycarbonate filter with 0.6μm pores (visible in the
images and can be used for size reference). A total of 100μL of cerebrospinal fluid was used from our patient, and 200μL from the healthy
control subject. Although only half the volume of control cerebrospinal fluid was used for our patient, the amyotrophic lateral sclerosis filters are
filled with compact aggregates of spherical particles of lipid appearance, sticking together in a viscous batter. This process can be clearly seen in
the image from our patient’s sample in the upper left corner (CSF I × 500) where the subcellular structures are closely attached, leaving the
remaining filter free of aggregates. Control filters (CSF I × 2000) and (CSF II × 2000) are free of particles except a tiny skin flake in the middle of the
control filter (CSF II × 2000).
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tive for CD45 and thus of leukocyte origin (leukoc-
tye-derived microparticles; LMPs). Our patient had
almost 400 times more LMPs in his CSF than the
four healthy control subjects had in theirs. The plate-
let (CD42a)-derived and endothelial cell-derived
(CD144) MPs were low and within similar ranges as
the healthy control subjects. The number of PS-MPand LMP in the first fraction of CSF was about 50%
higher than the MP events in the second CSF frac-
tion (Figure 3, Table 1). The scanning electron micro-
scopic evaluations of CSF of our patient showed
many spherical particles compared to no particles
seen in the CSF from the 14 healthy control subjects,
10 of whom were matched for age to our patient and
used only for the SEM analysis (Figure 1).
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Figure 2 Flow cytometry of two fractions of cerebrospinal fluid (CSF) from our patient with amyotrophic lateral sclerosis (ALS) and a
healthy control subject. Microparticles (MP), considered to have a size less than 1.0μm, were discriminated by their forward (FS) and side scatter
(SS) characteristics. These microparticles were then analyzed for specific binding of lactadherin (detects phosphatidylserine (PS)) and antibodies
towards CD42a (platelet microparticles), CD144 (endothelial microparticles) and CD45 (leukocyte microparticles) as presented in Table 1. The
scanning electron microscope (SEM) photographs (enlarged × 2000) of the same fractions of cerebrospinal fluid are inserted to the right of the
microparticle gates and further described in Figure 1.
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Microparticles carry identity proteins and bioactive
molecules from the parental cell. Their detection and
identification in the CSF may be considered as a direct
indicator of activation or damage from specific cells or
tissues. CSF was selected in the present case for its
closeness to CNS pathology in the motor neurons in the
anterior spinal horns in amyotrophic lateral sclerosis.
The clearance of apoptotic cells by phagocytes is an effi-
cient process. However, even in tissues that are known
to contain a large fraction of cells undergoing apoptosis(such as the bone marrow), it is difficult to detect apop-
tosis by traditional methods because the apoptotic cells
are rapidly engulfed by macrophages. The exposure of
phosphatidylserine that occurs during apoptosis is the
best-studied macrophage recognition signal, and several
receptors have been identified in macrophages that me-
diate apoptotic cell clearance by binding to phosphati-
dylserine on apoptotic cells directly or indirectly.
The number of SEM structures, which are likely emer-
ging from the fragments of the destruction of motor
neurons from the frontal spinal horn, corresponds to the
Table 1 Microparticles (MPs) in cerebrospinal fluid (CSF)
from our patient with amyotrophic lateral sclerosis (ALS)
and from four healthy controls, respectively
Individuals CSF fraction Phosphatidylserine CD42a CD144 CD45
Patient CSF I 3544 4 4 2526
Patient CSF II 2009 5 13 1873
Controls CSF I 32 9 2 6
Controls CSF II 31 8 1 7
Flow cytometry was used to detect microparticles from platelets (CD42a),
endothelial cells (CD144) and leukocytes (CD45) in the first (CSF I) and second
fraction (CSF II) of cerebrospinal fluid. The results are presented as number of
microparticles detected in the cerebrospinal fluid. See Figure 2 for further
information on the method.
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Figure 2). The destroyed lipid cell membranes of the leu-
kocytes are expected to form different sizes of spherical
particles when they aggregate and accumulate in the
CSF. The amount of particles in the CSF of our patient
seen under the microscope in the first CSF fraction com-
pared to the second CSF fraction indicates that there
was a gradient of the number of particles in the CSF
(Figure 3). This finding corresponds to the number of
MPs measured with the FACS technique. The gradient
in the number of particles may be explained by the anat-
omy of the peripheral cerebrospinal fluid outflow path-
way [9].
In general terms microglial phagocytosis of dead or






















Figure 3 Flow cytometry of phosphatidylserine (PS) and CD45
antibodies in two fractions of cerebrospinal fluid (CSF) in our
patient with amyotrophic lateral sclerosis (ALS). Number of
events (that is, number of microparticles [MPs]) detected during 45
seconds of measurement are shown on the y-axis. See Figure 2 for
further information on methodology.release of damaging inflammatory intracellular compo-
nents. However, there is evidence that under certain
conditions microglia can also phagocytose viable neu-
rons, thus initiating their death. Such phagocytic cell
death may result from exposure of PS as an ‘eat-me’ sig-
nal (for example, via receptor brain-specific angiogenesis
inhibitor 1; BAI 1) destroying otherwise viable neurons.
The neuronal cell death in ALS may start as a result of a
variety of alleged etiological factors such as genetic vul-
nerability or different toxic substrates, which may spread
neuronal phagocytosis by activated microglia [10].
In our patient lumbar puncture was performed before
the diagnosis of ALS was finally verified. We found
abundant LMPs in his CSF. The LMPs may have origi-
nated from neutrophils, monocytes or macrophages, and
lymphocytes. MPs express markers from their parental
cells and harbor membrane and cytoplasmic proteins as
well as bioactive lipids implicated in a variety of mecha-
nisms, maintaining or disrupting homeostasis. Both pro-
inflammatory and anti-inflammatory processes can be
affected in several ways by LMPs to ensure an appropri-
ate inflammatory response. LMPs have also been shown
to play a dual role in the endothelium by either improv-
ing the endothelial function or inducing an endothelial
dysfunction [11]. We did not find any MPs in CSF
derived from endothelial cells in our patient. Numbering
microparticles, including antibodies for LMPs, might be
useful in detecting early signs of ALS. Additional work is
of course needed to further investigate the overall role of
LMPs in ALS.
There is still no consensus on the etiology of ALS.
Researches show evidence of intoxication by heavy
metals, environmental and occupational causes, genetic
mutations, for example, of superoxide dismutase 1 [12]
or of D-amino acid oxidase with accumulation of D-
serine in the spinal cord [13], and viral infections. There
are also signs of more general apoptosis in patients with
ALS reflected as increase of caspase 9 in serum [14].
Due to this great diversity of possible causative agents
for ALS, it is necessary to elucidate many possible eti-
ologies for a better approach to patients, promoting pre-
ventive programs for the disease, optimizing functions
and improving the quality of life of the patients.
The two complementary methods presented in this
case report might help to diagnose the first signs of
pathophysiology in the CSF in larger sets of individuals
with high risk of developing ALS. Including more anti-
bodies as FACS markers in CSF studies may also be use-
ful in differentiating clinical subtypes of patients with
ALS as well as in diagnosing other neuropsychiatric dis-
eases. One advantage with the two matching methods is
that the results of both procedures may be available
within a short time (one hour) after the LP procedure.
The rapid analysis, which may easily be repeated in
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who develop and test new treatment forms for patients
with ALS.
Conclusions
Our 80-year-old patient with ALS symptomatology
showed 100 times more phosphatidylserine-positive MPs
and 400 times more cell-derived microparticles of
leukocyte origin in fresh CSF compared to healthy con-
trol subjects. The increased number of MPs may con-
tribute to the ALS inflammatory process by formation of
immune complexes and interact with prion-like propa-
gation of misfolded proteins in neural cells [15]. MPs
thus represent subcellular arrangements in ALS that
might serve as biomarkers for the disease. The two com-
plementary methods SEM and FACS used in this report
may be additional tools for rapid early diagnostic pur-
poses, in evaluating clinical trials and in follow-up studies
of patients with ALS, and for elucidating the pathogenesis
of ALS.
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